Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : How To Write Covered Calls - An Ongoing Real Case Study! -- Ignore unavailable to you. Want to Upgrade?

To: Herm who wrote (7324)	4/22/1998 6:54:00 PM
From: RayV	Read Replies (1) \| Respond to of 14162

Herm I'll put XRAY on my watch list. Sometimes it seems hard to know which of VectorVest's factors to pay the most attention to; For example what do you make of GPE (Growth to P/E Ratio): XRAY has a GPE of 0.73. On the other hand the value reading is great. Did you get a similar value reading from stocksmart on this one? Ray

To: Herm who wrote (7324)	4/22/1998 7:11:00 PM
From: Mike Learner	Read Replies (1) \| Respond to of 14162

To All: I am new here. I have looked at many informative informations you all have contributed here -- I would like to express my appreciation to you all -- Great effort I have few basic questions: 1) After selling calls, would it be wise to buy back same calls when the premium value drops 75% or more, 2) when underlying stock appreciates higher, at what percentage of the premium value should the calls be purchased back and sell calls with one strike higher with still being "in money"? and 3) Should NO. # 2 question be executed for same month or the month after? Could anyone help me with these questions since I need to study them and be prepared for tomorrow's session. Regards QuoteGuy

To: Herm who wrote (7324)	4/22/1998 9:24:00 PM
From: Andrew Williams	Read Replies (1) \| Respond to of 14162

XRAY is an interesting company that I use to work for from 1992 to 1995. XRAY was originally GENDEX and "merged" with Dentsply in 1994. I am surprised and glad to see the company has done well over the past year or so. After going through a period where product development and acquisitions were stagnant it appears that the pipeline is doing well which has led to a good run over the last 18 months. My observations from 1995 were that XRAY had strong sales and marketing capabilities, but relatively weak operations management at some divisions. Acquisitions during that time often clouded actual performance at continuing operations. Since XRAY is a manufacturer who distributes through large distributors like Patterson Dental and Henry Schein it might help to watch those companies also as an indicator of future Dentsply performance. Given the recent stock run, the call premies are starting to look attractive.